Syndax Pharmaceuticals, Inc. (SNDX)
17.90
+0.32
(+1.82%)
USD |
NASDAQ |
Jun 11, 16:00
17.90
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Max Drawdown (5Y) : 69.88% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 69.88% |
| April 30, 2026 | 69.88% |
| March 31, 2026 | 69.88% |
| February 28, 2026 | 69.88% |
| January 31, 2026 | 69.88% |
| December 31, 2025 | 69.88% |
| November 30, 2025 | 69.88% |
| October 31, 2025 | 69.88% |
| September 30, 2025 | 69.88% |
| August 31, 2025 | 69.88% |
| July 31, 2025 | 69.88% |
| June 30, 2025 | 69.29% |
| May 31, 2025 | 69.12% |
| April 30, 2025 | 63.70% |
| March 31, 2025 | 60.70% |
| February 28, 2025 | 60.70% |
| January 31, 2025 | 60.70% |
| December 31, 2024 | 61.18% |
| November 30, 2024 | 61.18% |
| October 31, 2024 | 61.18% |
| September 30, 2024 | 68.30% |
| August 31, 2024 | 68.30% |
| July 31, 2024 | 68.30% |
| June 30, 2024 | 68.30% |
| May 31, 2024 | 68.30% |
| Date | Value |
|---|---|
| April 30, 2024 | 68.30% |
| March 31, 2024 | 71.40% |
| February 29, 2024 | 73.15% |
| January 31, 2024 | 73.15% |
| December 31, 2023 | 75.13% |
| November 30, 2023 | 78.98% |
| October 31, 2023 | 78.98% |
| September 30, 2023 | 78.98% |
| August 31, 2023 | 78.98% |
| July 31, 2023 | 78.98% |
| June 30, 2023 | 78.98% |
| May 31, 2023 | 78.98% |
| April 30, 2023 | 78.98% |
| March 31, 2023 | 78.98% |
| February 28, 2023 | 78.98% |
| January 31, 2023 | 78.98% |
| December 31, 2022 | 78.98% |
| November 30, 2022 | 78.98% |
| October 31, 2022 | 78.98% |
| September 30, 2022 | 78.98% |
| August 31, 2022 | 78.98% |
| July 31, 2022 | 78.98% |
| June 30, 2022 | 78.98% |
| May 31, 2022 | 78.98% |
| April 30, 2022 | 78.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biogen, Inc. | 72.66% |
| Celldex Therapeutics, Inc. | 73.11% |
| Viridian Therapeutics, Inc. | 95.92% |
| Ardelyx, Inc. | 95.65% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.282 |
| Beta (5Y) | 0.3812 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.52% |
| Historical Sharpe Ratio (5Y) | -0.0402 |
| Historical Sortino (5Y) | -0.0846 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.33% |